Dr. Cooper earned her medical degree from the Sackler School of Medicine at the University of Tel Aviv in Israel, where she grew up. She completed her training in neurology at the University of California, Davis and is board certified in neurology and in sleep disorders medicine. In addition to her experience in general neurology and in sleep medicine, Dr. Cooper has extensive experience treating people with multiple sclerosis. She has specialized training and clinical research experience in the treatment of severe spasticity using techniques such as botulinum toxin injections and intrathecal baclofen infusion systems. Dr. Cooper serves on the boards of a number of community organizations. She is assistant clinical professor at the University of Californian, San Francisco School of Nursing, and she is an adjunct assistant clinical professor at Touro University.
Sutter Health Research Enterprise
2850 Telegraph Avenue, Suite 110
Berkeley, CA, 94705
(510) 204-0498
CooperJ2@sutterhealth.org
Primary Research Interests
Related Clinical Trials
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progr
A PHASE III MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE DUMMY, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB IN ADULTS WITH PROGRES
Investigators: Matthew W. Arnold M.D., David Eric Collins MD, Joanna A. Cooper M.D., Aryn Earnhardt NP, Lynn Jehle NP, Antonio J Silva-Sayago MD, Bradley T Wrubel MD
Status: Active, Recruiting
M14
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Investigator: Joanna A. Cooper M.D.
Status: Completed
M18
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Investigator: Joanna A. Cooper M.D.
Status: Completed